Respiratory viral infections are a distinct risk for bronchiolitis obliterans syndrome and death.
about
The lung microbiome after lung transplantationRespiratory viral infections in hematopoietic stem cell and solid organ transplant recipientsThe role of autoimmunity in obliterative bronchiolitis after lung transplantationGraft Loss and CLAD-Onset Is Hastened by Viral Pneumonia After Lung TransplantationChallenges in the diagnosis of 2009 H1N1 in a lung transplant patient and the long-term implications for prevention and treatment: a case report.The impact of pandemic influenza A H1N1 2009 on Australian lung transplant recipients.The role of the bacterial microbiome in lung diseaseChanges in the lung microbiome following lung transplantation include the emergence of two distinct Pseudomonas species with distinct clinical associations.Azithromycin is associated with increased survival in lung transplant recipients with bronchiolitis obliterans syndrome.Mechanisms of chronic rejection in cardiothoracic transplantation.Selecting suitable solid organ transplant donors: Reducing the risk of donor-transmitted infectionsLong-term impact of respiratory viral infection after pediatric lung transplantation.Prevention of airway allograft tolerance by polyinosinic:polycytidylic acid requires type I interferon responsiveness for mouse airway obliterationUsefulness of immune monitoring in lung transplantation using adenosine triphosphate production in activated lymphocytes.Aspergillus colonization of the lung allograft is a risk factor for bronchiolitis obliterans syndromeImproved characterization of medically relevant fungi in the human respiratory tract using next-generation sequencing.Mechanistic differences between phenotypes of chronic lung allograft dysfunction after lung transplantation.Incidence, Risk Factors and Outcomes of Delayed-onset Cytomegalovirus Disease in a Large Retrospective Cohort of Lung Transplant Recipients.Interstitial lung disease, lung cancer, lung transplantation, pulmonary vascular disorders, and sleep-disordered breathing in AJRCCM in 2004.IL-17-dependent cellular immunity to collagen type V predisposes to obliterative bronchiolitis in human lung transplants.Antibodies to K-α 1 tubulin and collagen V are associated with chronic rejection after lung transplantationLung transplantation: opportunities for research and clinical advancement.Respiratory virus-induced dysregulation of T-regulatory cells leads to chronic rejection.Challenges in pulmonary fibrosis. 2: Bronchiolocentric fibrosis.Pathogenesis of respiratory syncytial virus infection in the murine modelA patient self-collection method for longitudinal monitoring of respiratory virus infection in solid organ transplant recipientsTransplant-related immunosuppression: a review of immunosuppression and pulmonary infectionsLung-enriched organisms and aberrant bacterial and fungal respiratory microbiota after lung transplant.Metagenomic sequencing complements routine diagnostics in identifying viral pathogens in lung transplant recipients with unknown etiology of respiratory infectionInnate immunity and organ transplantation: focus on lung transplantation.Symptomatic Respiratory Virus Infection and Chronic Lung Allograft DysfunctionRhinovirus and other respiratory viruses exert different effects on lung allograft function that are not mediated through acute rejection.Bronchiolitis obliterans syndrome: the Achilles' heel of lung transplantation.American Society of Transplantation executive summary on pediatric lung transplantation.Colonization with small conidia Aspergillus species is associated with bronchiolitis obliterans syndrome: a two-center validation studyPersistence of influenza vaccine-induced antibody in lung transplant patients and healthy individuals beyond the season.Outcome of respiratory syncytial virus lower respiratory tract disease in hematopoietic cell transplant recipients receiving aerosolized ribavirin: significance of stem cell source and oxygen requirement.Allopeptides and the alloimmune response.The Role of TGF-β in the Association Between Primary Graft Dysfunction and Bronchiolitis Obliterans Syndrome.IL-12 p80 is an innate epithelial cell effector that mediates chronic allograft dysfunction
P2860
Q26825397-4147A6A5-F481-4A81-9478-29EA49F27E09Q26829188-43A2C360-88B6-4408-BBA9-6A212CB348DCQ27008934-BD0986DE-4278-4877-AA20-F6A1E4CA5B4CQ28392376-3EE02FE6-D1D7-430A-876B-C73585216E11Q30397634-4650BC5E-C52D-4C60-BF95-5338DDCCE0F8Q30399407-B789AFAA-1E09-4695-BFA6-B0B9264E7567Q33554623-18310022-940F-4386-A8C2-F7EC047E3421Q33617931-21B5531F-4E57-407F-89CF-1644A2371F70Q33788054-DE84A3BB-89F3-4E17-8A3C-7DC4BBAB6916Q33841493-286749E6-0FC8-4EEB-9426-2586BB23F72EQ33891744-508D0EC2-E37A-4433-91FF-0E2EB0434D09Q33945973-C667E734-5624-43B4-84E1-D83177E5C957Q34372089-B12B1ECA-2370-4F4A-BB93-E93421A7920EQ34378856-FB941204-9007-41F4-816B-83B54DA6985CQ34427034-40B72039-5F97-4764-A2C6-ED546DBDC6EBQ34515243-19D3E51F-729D-4637-ADD1-0F401C68F5EFQ34803336-51B1F7C7-B086-4AFF-A808-4BD790DF89CCQ35946563-452FD56F-E788-4D48-B99D-F7B4D794EB53Q36080140-198DD1B7-19E3-4B47-9145-DAB652E9C365Q36088927-E850B56B-718D-4604-9FB9-EC3A3C894A0CQ36131035-D85A1C15-6215-4B7A-8B8E-42B0496DF6ECQ36195432-4847A9D9-00E5-498D-9E66-F0AD2B3B4023Q36206278-1DF3502E-81FF-4146-8E86-7BA002E911E1Q36225775-F696E1DF-EAE2-4F93-88D1-70EF29D91D54Q36237028-5A12C681-EBE7-455B-A732-00ACA94C10E1Q36238022-8BE93E58-3889-4234-A651-855A19A846A8Q36328703-3299ED23-5F76-4020-B9EB-FA06754C8FA1Q36345291-9195DE89-DBC0-4C4C-AD27-21805443EDF0Q36380118-E7F8EF32-61BB-4758-AFCE-E2D5B124E835Q36420171-D6972AD3-1DB1-4C98-ABF6-B274DEEF879BQ36446117-6B261DBA-3B45-4B21-8036-F33304D83782Q36572643-58A17C5B-9102-4A56-9DAF-E3939415A570Q36623201-5A056753-2972-474E-A744-C22291396E62Q36655282-BCD5B143-E6A5-4609-9E84-74D493E25E24Q36745407-0E252133-631E-4CBC-AB62-88340A20FB60Q36849805-5DA3C545-DB9D-4E1F-BA30-EE5CB6D2D8E5Q36886930-8647EA51-D205-426B-87BF-9465FBAB9093Q37006610-9244D191-6A86-444E-8283-8EA0C0D3C915Q37097926-31CA9823-6885-49DA-8F23-9D8143E350F7Q37110366-17C292C5-4C4E-45C2-A86A-892AA2BA0D15
P2860
Respiratory viral infections are a distinct risk for bronchiolitis obliterans syndrome and death.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Respiratory viral infections a ...... obliterans syndrome and death.
@en
Respiratory viral infections a ...... obliterans syndrome and death.
@nl
type
label
Respiratory viral infections a ...... obliterans syndrome and death.
@en
Respiratory viral infections a ...... obliterans syndrome and death.
@nl
prefLabel
Respiratory viral infections a ...... obliterans syndrome and death.
@en
Respiratory viral infections a ...... obliterans syndrome and death.
@nl
P2093
P1476
Respiratory viral infections a ...... obliterans syndrome and death.
@en
P2093
Anthony P Khalifah
Daniel P Schuster
Elbert P Trulock
G Alexander Patterson
Kenneth B Schechtman
Michael J Walter
Murali M Chakinala
Ramsey R Hachem
Thalachallour Mohanakumar
P304
P356
10.1164/RCCM.200310-1359OC
P407
P577
2004-05-06T00:00:00Z